Revelation Biosciences, Inc.
REVB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,907 | -$2,444 | -$2,051 | -$1,726 |
| Dep. & Amort. | $7 | $7 | $7 | $7 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1 | $1 | $223 | $0 |
| Change in WC | $307 | $517 | -$979 | -$2,099 |
| Other Non-Cash | $4 | -$0 | $5 | $70 |
| Operating Cash Flow | -$1,589 | -$1,919 | -$2,794 | -$3,748 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $18 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $18 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $3,388 | $0 | $3,688 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9,124 | $0 | $0 | $0 |
| Financing Cash Flow | $9,124 | $3,389 | $0 | $3,688 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $7,535 | $1,469 | -$2,794 | -$42 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,174 | $3,705 | $6,499 | $6,541 |
| End Cash | $12,708 | $5,174 | $3,705 | $6,499 |
| Free Cash Flow | -$1,589 | -$1,919 | -$2,794 | -$3,730 |